Leave No Stent Behind: Are Drug-Coated Balloons Enough for Femoropopliteal Disease?

Affiliations

¹ From the Center for Interventional Vascular Therapy, Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York Presbyterian Hospital.
² From the Center for Interventional Vascular Therapy, Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York Presbyterian Hospital. sap2196@cumc.columbia.edu.

Editorial

Sanjum S Sethi et al. Circ Cardiovasc Interv. 2018 Jan.

. 2018 Jan;11(1):e006285.

doi: 10.1161/CIRCINTERVENTIONS.117.006285.

¹ From the Center for Interventional Vascular Therapy, Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York Presbyterian Hospital.
² From the Center for Interventional Vascular Therapy, Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York Presbyterian Hospital. sap2196@cumc.columbia.edu.

No abstract available

Keywords: Editorials; angioplasty; diabetes mellitus; hyperplasia; neointimal; nitinol; paclitaxel.

Comment on

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P; IN.PACT SFA Trial Investigators. Schneider PA, et al. Circ Cardiovasc Interv. 2018 Jan;11(1):e005891. doi: 10.1161/CIRCINTERVENTIONS.117.005891. Circ Cardiovasc Interv. 2018. PMID: 29326153 Free PMC article. Clinical Trial.